Ugandan authorities are using the cover of COVID-19 pandemic emergency powers to crack down on LGBTQ+ people, targeting them for arrest and extortion, a 

South Africa is facing a “trio of pandemics”—HIV, tuberculosis, and the newcomer, COVID-19.   Little is known about the impact of adding COVID-19 into the mix. Western Cape regional data show that people living with HIV or active TB had more than twice the risk of dying…

Well before COVID-19, the built environment was informed by the legacy of disease pandemics.  

COVID-19’s lethal invasion in late 2019 has turned the world inside out. Yet, another disease, tuberculosis, has been plaguing humans since the Upper Paleolithic era, some 20,000 years ago. In fact, many infection-prevention precautions promoted for the coronavirus—coughing…

A new, 6-month treatment has cured 90% of people with stubborn drug-resistant tuberculosis—who typically face limited treatment options and poor outcomes, according to clinical trial results published today in The New England Journal of Medicine.

Infectious killer TB has a single vaccine: bacille Calmette-Guérin. A recent study found that BCG developed in different countries varies wildly in the numbers of live bacteria it contains—some have 10–1,000X more others. “Imagine we marketed a heart medication and some…

Funding for HIV and TB is falling off, as international donors try to shift more costs to affected countries—upping the risks of “epidemic rebound,” Médecins Sans Frontières warns in a report released yesterday

While Russia has made strides in tackling NCDs and TB, its policies pose a grave threat the control of other global health concerns like HIV.   A laundry list of antagonistic actions have overshadowed Russia’s global health efforts. On certain issues, the country’s approach…

Determined to improve on 1-way, easy-to-ignore reminders for tuberculosis patients to take their medicine, MIT researchers in Kenya embarked on an experiment, reports MedicalXpress.  

Yesterday the FDA greenlit a hugely promising drug for a form of TB that has long been a death sentence, The New York Times reports.   Pretomanid is part of a 3-drug regimen that proved 90% effective against extensively drug-resistant TB, according to preliminary trial…